The “Medical Bypass”: new drugs to strike obesity
Pharmaceutical Technology
NOVEMBER 30, 2022
The drug was approved to treat type 2 diabetes mellitus in May. A 2017–2018 National Health and Nutrition Examination Survey (NHANES), showed that 30.7% In the first quarter since its launch as an approved therapy for type 2 diabetes, Mounjaro has proven to be a lucrative drug, making $97.3 The same can be said for the US.
Let's personalize your content